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INTRODUCTION
Cord blood (CB) stem cells are increasingly being used as
a source of hematopoietic stem cells transplantation (HSCT).
Although there are several advantages, such as a lower inci-
dence of graft-versus-host disease (GVHD) or viral infections
in cord blood stem cell transplantation (CBSCT) as compared
to bone marrow transplantation (BMT), slower engraftment
speed and the limitation of the cell dose are still obstacles
(1-5). Recent studies regarding the homing mechanism fol-
lowing HSCT have revealed that homing-associated cell adhe-
sion molecules (H-CAMs) and chemokine receptors on the
CD34+ cells play very important roles for engraftment (6, 7).
Until recently, most studies on H-CAMs have been common-
ly performed by using purified CD34+ cells, and the quan-
tity of these cells is expressed as percentages of positive cells
or as the antigen density on the CD34+ cells (8-11). 
Although most of the CAMs including CD49d, CD44
and CXCR4, are present on primitive hematopoietic cells,
they are also found on another nucleated cells (NCs) includ-
ing monocytes and lymphocytes (12-15). Therefore, not only
CD34+ cells but also the other NCs expressing H-CAMs
and chemokine receptors could be implicated in the engraft-
ment and proliferation of hematopoietic stem cells. Further-
more, in CBSCT, the speed of myeloid engraftment was pri-
marily associated with the total nucleated cell (TNC) counts
rather than the CD34+ cell counts (2). 
Although recent study revealed that trafficking of trans-
planted cells to the bone marrow is not selective and lodgment
of bone marrow-homed cells may be specific (16), engraft-
ment potential of HSCs may be influenced by the distinct
phases of cell cycle (17, 18). 
A lot of studies showed a significant delay of neutrophil
and platelet recovery in the CBSCT group compared with the
BMT or peripheral blood stem cell transplantation (PBSCT)
groups. The studies have also revealed that the median cell
doses for engraftment are significantly lower in the CBSCT
group compared with the BMT or PBSCT groups (2, 5, 19,
20). However, to date it is not clear why the engraftment
speed is different and the required cell dose for engraftment
is different among these groups. In the present study, to deter-
mine the engraftment kinetics, we investigated the differ-
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Homing-Associated Cell Adhesion Molecules and Cell Cycle Status
on the Nucleated Cells in the Bone Marrow, Mobilized Peripheral
Blood and Cord Blood
Homing-associated cell adhesion molecules (H-CAM) on the CD34+ cells play an
important role for the engraftment process following hematopoietic stem cell trans-
plantation (HSCT). However, it seems that not only CD34+ cells but also other nucle-
ated cells (NCs) with H-CAM could be implicated in the engraftment process and
the proliferation of hematopoietic stem cells. We investigated the differences of H-
CAM and cell cycle status on the NCs in cord blood (CB), bone marrow (BM), and
mobilized peripheral blood (PB). The proportions of CXCR4+ cells within the NC
populations were greater in CB than in PB or BM (p=0.0493), although the propor-
tions of CXCR4+, CD44+, and CD49d+ cells within the CB CD34+ cell populations
were same within BM or PB. A lower proportion of CD34+CD49d+ cells within the
CD34+ cell populations was more noted in CB than in PB or BM (p=0.0085). There
were no differences in cell cycle status between CB and BM or PB. Our results sug-
gest that the migrating potential of CB would be enhanced with increased CXCR4
expression on the NCs, but the adhesion potential of CB CD34+ cells would be less
than that of PB and BM. These findings may help explain why the lower cell dose
is required and engraftment is delayed in cord blood stem cell transplantation.
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ences of H-CAMs and chemokine receptors as well as cell
cycle status by using the NCs, not the purified CD34+ cells,
in the bone marrow (BM), mobilized peripheral blood (PB)
and the CB.
MATERIALS AND METHODS
Isolation of nucleated cells from 3 different sources of
stem cells
Eight BM samples were obtained from normal healthy
donor for related BMT, and these cells were cryopreserved
after a red cell depletion process by density gradient separ-
tion with 10% pentastarch (Jeil Pharm, Seoul, Korea), and
the cells were then analysed after thawing. Ten PB samples
were obtained from the apheresed products of acute myel-
ogenous leukemia patients, which were collected after mobi-
lization chemotherapy for the PBSC harvest.
Thirteen CB samples were collected into transfer bags con-
taining acid citrate dextrose (ACD) from the umbilical cord
vein immediately after a full-term vaginal delivery, and the
red cells were depleted by the same method as was used with
the BM.
Phenotype analysis
Dual-color flow cytometry of CD34/CXCR4, CD34/49d,
CD34/44 for the isolated nucleated cells was performed using
FACSort (Becton Dickinson, San Jose, CA, U.S.A.). The cells
were stained with the corresponding monoclonal antibodies
for 45 min. After incubation, the cells were then washed three
times in phosphate-buffered saline (PBS), fixed in 1% para-
formaldehyde, and finally analysed by using Lysys II software
(Becton Dickinson, San Jose, CA, U.S.A.).
Cell cycle analysis
The cells were washed two times with PBS by centrifuga-
tion for 3 min at 4℃, then they were fixed with 50% ethanol
for 30 min at room temperature. Cells were suspended in
PBS containing RNase (1 mg/mL, 20  L) and propidium
iodide (10 mg/mL, 2.5  L), and they were incubated for 30
min at room temperature. The cell cycle was analysed with
Multicycle using Coulter EPICS XL flow cytometer (Beck-
man Coulter, FL, U.S.A.).
Statistical analysis
Student’s t-test and the Wilcoxon rank sum test were per-
formed between CB and BM, and also on the differences bet-
ween the CB and PB. The SAS window version 6.12 was used
for our analysis.
RESULTS
CXCR4, CD49d, and CD44 expression on the NCs 
The proportions of CXCR4+ cells in the NCs were sig-
nificantly higher in CB (82.76±5.89%) than in BM (62.31
±15.64%) or PB (76.35±23.7) (p=0.0493). However, the
percentages of CD49d+ and CD44+ cells in CB were not
statistically different from BM or PB. (Table 1, Fig. 1)
The percentage of CD34+CXCR4+, CD34+CD49d+, and
CD34+CD44+ cells within the NC populations and within
the CD34+ cell populations
Although the CD34+CXCR4+ and CD34+CD44+ cells
within the NC populations in CB were not statistically dif-
ferent from PB or BM, the CD34+CD49d+ cells were sig-
nificantly lower in CB (0.91±0.49%) than in BM (2.38±
1.19%) or PB (4.23±3.14%) (p=0.0085) (Table 2). How-
ever, in the CB CD34+ cell populations, the proportions of
CD34+CXCR4+, CD34+CD49d+, and CD34+CD44+
cells were not significantly different from BM or PB (Table 3).
Values given represent a mean±the standard deviation. CB, cord blood;
BM, bone marrow; PB, peripheral blood; *: significant difference between
CB and BM; 
� : significant difference between CB and PB.
CB (n=13) BM (n=8) PB (n=10)
CXCR4+ cells (%) 82.76±5.89 62.31±15.64* 76.35±23.7
�
CD49d+ cells (%) 94.20±7.18 83.48±13.86 86.49±10.44
CD44+ cells (%) 98.61±1.3 98.65±1.14 98.51±1.73
Table 1. The proportions of CXCR4+, CD49d+, and CD44+ cells
within the NC populations
Values given represent a mean±the standard deviation. CB, cord blood;
BM, bone marrow; PB, peripheral blood; *: significant difference between
CB and BM; 
� : significant difference between CB and PB.
CB (n=13) BM (n=8) PB (n=10)
CD34+CXCR4+ cells (%) 0.95±0.49 2.09±0.83 3.46±3.37
CD34+CD49d+ cells (%) 0.91±0.49 2.38±1.19* 4.23±3.14
�
CD34+CD44+ cells (%) 1.52±0.64 2.06±0.97 5.17±3.65
Table 2. The proportions of CD34+ cells expressing CXCR4,
CD49d, and CD44 within the NC populations
Values given represent a mean±the standard deviation. CB, cord blood;
BM, bone marrow; PB, peripheral blood.
CB (n=13) BM (n=8) PB (n=10)
CD34+CXCR4+ cells (%) 94.11±7.11 82.54±12.93 74.81±30.71
CD34+CD49d+ cells (%) 97.90±2.38 98.46±2.56 91.29±10.42
CD34+CD44+ cells (%) 98.24±1.51 99.00±1.54 98.66±1.66
Table 3. The proportions of CD34+ cells expressing CXCR4,
CD49d, and CD44 within the CD34+ cell populations Cell cycle status 
Most of NCs of CB (87.83±6.71%), BM (87.62±5.01%),
and PB (88.38±32%) were in G0/G1 phase and they were
not statistically different. The cell fractions in S/G2/M phase
showed no significant differences between those fractions in
CB (12.17±6.75%) and BM (12.4±5.07%) or PB (11.6
±1.35%) (Fig. 2).
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Fig. 1. Representative flow cytometric profile of CXCR4, CD44, CD49d and CD34 expression on the isolated nucleated cells from bone
marrow (BM), mobilized peripheral blood (PB) and cord blood (CB).
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BM PB CBDISCUSSION 
In hematopoietic stem cell transplantations, CB offers sub-
stantial advantages when compared to BM or PB. There is the
rapid availability of cells and the less stringent requirements
for HLA identity between the donor and recipient because
of the lower risk of acute and chronic graft versus host disease.
The major disadvantage of CBSCT is the delayed recovery
of neutrophils and platelets, which could increase the risk of
life-threatening infections and bleedings (4, 5). Although the
engraftment following CBSCT is strongly correlated with
infused nucleated cell numbers (2), very little is known about
why the engraftment speed is slower in CBSCT than in BMT
or PBSCT.
To rescue the patient’s hematopoietic systems after myeloab-
lative chemo- or radiotherapy, the intravenously transplant-
ed hematopoietic stem cells (HSCs) have to migrate to the
bone marrow’s microenvironment for their ultimate prolif-
eration and differentiation. In this homing process, various
adhesion molecules present on both HSC and endothelial
cells are involved (6, 7). The CD34+ cells exhibit other adhe-
sion receptors they are involved in the multistep process of
HSCT: homing in to the BM, adhesion to the BM microen-
vironment and finally, the stem cell differentiation. CXCR4
is a dominantly expressed chemokine receptor on primitive
human blood cells within all stages of human development
(21). Stromal cell-derived factor-1 (SDF-1), which is produced
by stromal cells in various organs, is a powerful chemoattrac-
tant for its receptor CXCR4. The SDF-1/CXCR-4 interac-
tion is clinically relevant during embryonic development,
hematopoiesis and the migration of CD34+ stem cells. We
revealed that although the proportions of CD34+CXCR4+
cells within the NC or CD34+ cell populations were not
statistically different in BM, PB and CB, the proportions of
CXCR4+ cells in NC populations were significantly higher
in CB than in BM or PB. These results suggest that NCs,
except CD34+ cells expressing CXCR4, were more abun-
dant in CB than in BM or PB.
The integrins, such as VLA-4 or VLA-5, they mediate the
adhesion of HSC to extracellular matrix proteins. The mobi-
lization of BM CD34+ cells into the PB is followed by a de-
crease of VLA-4 and VLA-5 expression (22, 23), and the low
frequency of CD49d+ on PB CD34+ cells has been also report-
ed by many authors (24-27). In our study, we observed the
same percentage of CD49d+ cells within the CD34+ cell pop-
ulations in the BM, PB and CB. However, CD34+CD49d+
cells within the NC populations in the CB were significant-
ly lower than in BM or PB.
In conclusion, our results suggest that the migrating poten-
tial of CB would be enhanced with increased CXCR4 expres-
sion on the NCs. However, the adhesion potential of CB
CD34+ cells would be less than that of PB and BM because
of the lower expression of CD34+CD49d+ cells within the
NC populations. These findings may help explain why the
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Fig. 2. Representative cell cycle analysis of the isolated nucleated
cells from bone marrow (BM), mobilized peripheral blood (PB) and
cord blood (CB).
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lower CB cell dose is required and engraftment is delayed in
CBSCT.
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